The Results and Outcomes of the Modified Swedish Adjustable Gastric Band (SAGB-VC) (ROS)
Since a few years the SAGB-VC is used in our clinic. This type of band has a number of advantages when compared to the earlier versions of the adjustable gastric band (AGB), reducing the chances on leakage, tube disconnection and port problems. In our clinic the follow up is strict. All patients are required to follow a special follow-up program in which the patient is seen 19 times during the first two years after SAGB-VC placement.
This is the first retrospective clinical study of a large study population of >800 patients in which a SAGB-VC was placed. This study was conducted to evaluate the results and the efficiency of the SAGB-VC in our clinic.
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||The Results and Outcomes of the SAGB-VC in a High Volume Bariatric Centre|
- Weight loss [ Time Frame: 2 months ] [ Designated as safety issue: No ]The amount of weight loss over time is researched
- Bariatric Analysis and Reporting Outcome System (BAROS) score [ Time Frame: 2 months ] [ Designated as safety issue: No ]A specific score for quality of life (QOL) and outcome for bariatric surgery is inventorized
- Operating time [ Time Frame: 2 months ] [ Designated as safety issue: No ]Operating time is inventorized
- Complications [ Time Frame: 2 months ] [ Designated as safety issue: No ]Complications are inventorized
- Co-morbidities [ Time Frame: 2 months ] [ Designated as safety issue: No ]The reduction of co-morbidities is inventorized
|Study Start Date:||March 2010|
|Study Completion Date:||July 2011|
|Primary Completion Date:||June 2011 (Final data collection date for primary outcome measure)|
SAGB VC group
Retrospectively patients with a SAGB-VC gastric band are inventorized. They will also be interviewed and BAROS scores will be taken.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01084915
|Arnhem, Gelderland, Netherlands, 6800 TA|
|Principal Investigator:||F.J. Berends, MD, PhD||Rijnstate Hospital The Netherlands|